Inhibitors of F18+ E Coli Binding
The present invention relates to blood group A/B/H determinant on Type 1 Core glycosphingolipids chains as recognition point for the FedF protein of F18-fimbriated Enterotoxigenic and verotoxinogenic Escherichia coli and the use of compounds comprising such determinants for the treatment of F18+ E. coli infections in pigs and in screening methods.
CODDENS ANNELIES [BE]; COX ERIC [BE]; TENEBERG SUSANN EVA [SE]
Type of Offer:
« More Biotech Patents